AbbVie

AbbVie is a publicly traded research-driven biopharmaceutical company that began as a spinoff from Abbott Laboratories in 2013. With a workforce of roughly 47,000, AbbVie prides itself on coming up with new treatments for chronic conditions and life-threatening illnesses, and its drugs are some of the world’s bestsellers, including cancer treatment Imbruvica and Humira, an immunosuppressant used to treat arthritis and Crohn’s disease. In 2016, AbbVie acquired Stemcentrx for $5.8 billion as part of a campaign to bolster its oncology research division. In 2020, AbbVie completed its purchase of Allergan, an Irish drug manufacturer, for $63 billion.